Results 231 to 240 of about 10,513,249 (295)
Dosage and Administration-Related Emotional and Clinical Outcomes of Buprenorphine Treatment for Opioid Use Disorder: A Systematic Review and Meta-Analysis. [PDF]
Xiao Y, Ramos MR, Montgomery-Marks P.
europepmc +1 more source
Abstract Background and aims Decriminalization of personal possession of select illegal drugs was implemented in British Columbia, Canada, for a three‐year period starting 31 January 2023; however, following perceived increases in public drug use and disorder, an amendment introduced on 7 May 2024 rolled back key provisions.
Jürgen Rehm +5 more
wiley +1 more source
ABSTRACT This scoping review explored the prevalence of work‐related psychological and physical health issues among Australian dental practitioners, mapped across key occupational hazard domains (psychosocial/organisational, physical/ergonomic and environmental/infection‐related) and summarised reported impacts on practitioner well‐being and workforce ...
Negar Jamshidi +5 more
wiley +1 more source
Opioid Therapy Discontinuation in General Practice: Associations with Adjunct Therapies and Somatoform Pain Disorders. [PDF]
Brinkmöller S +3 more
europepmc +1 more source
Understanding Estrogen Circuit-Level Effects Important for Targeted Interventions in Psychiatric Disorders. [PDF]
Milner TA.
europepmc +1 more source
Extended-release injection vs sublingual buprenorphine for illicit opioid use in pregnant patients with depression and/or anxiety. [PDF]
Cochran G +13 more
europepmc +1 more source
Receipt of Pharmacotherapy and Association with Healthcare Utilization Among US Adults with Alcohol or Opioid Use Disorder, 2022-2023. [PDF]
Pham DX, Nagavally S, Hawks LC.
europepmc +1 more source

